This website is intended for healthcare professionals only.

Hospital Healthcare Europe
Hospital Pharmacy Europe     Newsletter       

Oncology

18
Lymphoseek may be alternative to elective neck dissection to stage oral cancer
Lymphoseek may be alternative to elective neck dissection to stage oral cancer
Read more
Teva receives positive opinion from CHMP to extend indication of Trisenox®
Teva receives positive opinion from CHMP to extend indication of Trisenox®
Read more
The Prostate Cancer Registry treatment outcomes data presented for the first time at ESMO 2016
The Prostate Cancer Registry treatment outcomes data presented for the first time at ESMO 2016
Read more
New type of immunotherapy from Roche UK boosts survival in most common lung cancer
New type of immunotherapy from Roche UK boosts survival in most common lung cancer
Read more
Automated breast ultrasound detects significantly more invasive cancers in dense breasts
Automated breast ultrasound detects significantly more invasive cancers in dense breasts
Read more
Xofigo® recommended for prostate cancer with bone metastases in an additional group
Xofigo® recommended for prostate cancer with bone metastases in an additional group
Read more
Janssen submits application to the EMA to expand use of daratumumab
Janssen submits application to the EMA to expand use of daratumumab
Read more
Venetoclax receives positive opinion for chronic lymphocytic leukaemia in the UK
Venetoclax receives positive opinion for chronic lymphocytic leukaemia in the UK
Read more
NICE draft recommendation on the use of Nexavar® (sorafenib) in liver cancer
NICE draft recommendation on the use of Nexavar® (sorafenib) in liver cancer
Read more
Relapsed or refractory Hodgkin lymphoma patients could be denied access to innovative medicine
Relapsed or refractory Hodgkin lymphoma patients could be denied access to innovative medicine
Read more
Keytruda® approved by EC for specific population of patients with advanced NSCLC
Keytruda® approved by EC for specific population of patients with advanced NSCLC
Read more
Warning as skin cancer rates double in 20 years
Warning as skin cancer rates double in 20 years
Read more
Spectrila enters the UK market for the treatment of acute lymphoblastic leukaemia
Spectrila enters the UK market for the treatment of acute lymphoblastic leukaemia
Read more
Neuroendocrine tumour service named as Centre of Excellence
Neuroendocrine tumour service named as Centre of Excellence
Read more
Cabometyx™ receives positive opinion in advanced kidney cancer in the UK
Cabometyx™ receives positive opinion in advanced kidney cancer in the UK
Read more
European Commission approves extended indication for Kyprolis® for relapsed multiple myeloma patients
European Commission approves extended indication for Kyprolis® for relapsed multiple myeloma patients
Read more
Firmagon® recommended for advanced prostate cancer with spinal metastases
Firmagon® recommended for advanced prostate cancer with spinal metastases
Read more
Updated NICE quality standard recommends Oncotype DX® in early-stage breast cancer
Updated NICE quality standard recommends Oncotype DX® in early-stage breast cancer
Read more

Popular articles

Redefining management of uveal melanoma liver metastases: what oncologists need to know
Diagnostic AI tool ‘more accurate’ than physicians aims to ‘reshape’ healthcare
Be alert to Guillain-Barré risk after RSV vaccination in older adults, says MHRA
Forgo radioiodine ablation after thyroidectomy in low-risk cancer patients, say researchers
P2Y12 inhibitor monotherapy has lower MACCE risk than aspirin after PCI, study finds



 
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x